tiprankstipranks
Trending News
More News >
Edgewell Personal Care Co (EPC)
:EPC

Edgewell Personal Care (EPC) AI Stock Analysis

Compare
128 Followers

Top Page

EP

Edgewell Personal Care

(NYSE:EPC)

Rating:65Neutral
Price Target:
$27.00
▲(16.58%Upside)
Edgewell Personal Care's overall stock score is driven by stable financial performance and fair valuation. However, the bearish technical indicators and cautious outlook from the recent earnings call weigh down the score. Despite strong international growth, challenges in North American sales and cost impacts from tariffs present risks.
Positive Factors
International Growth
International saw growth from both volume and price and across the Wet Shave and Sun & Skin business.
Market Share Improvement
Category trends and Edgewell's market shares in North America improved as it exited the quarter.
Strategic Reinvestment
The company is stepping up its reinvestment spend next quarter to support promising campaigns in US Women's Shave and Sun.
Negative Factors
Guidance Reduction
Management lowered guidance and earnings expectations for the year on the weaker 2Q results and lowered earnings expectations due to incremental tariff pressures, increased promo investment needed, and higher A&P expectations.
Organic Sales Growth Issues
Edgewell's organic sales growth fell short of its own and Street estimates this quarter and the company cut its sales and earnings guidance for the full year.
Tariff and Cost Challenges
Tariffs have thrown another wrench in EPC's recovery in North America leading to increased cost and consumer uncertainty.

Edgewell Personal Care (EPC) vs. SPDR S&P 500 ETF (SPY)

Edgewell Personal Care Business Overview & Revenue Model

Company DescriptionEdgewell Personal Care Company is a leading consumer products company that specializes in the production and distribution of personal care products. The company operates in sectors including grooming, sun care, and skin care, with a diverse portfolio of well-known brands such as Schick, Wilkinson Sword, Edge, Skintimate, Banana Boat, Hawaiian Tropic, and Wet Ones. Edgewell is committed to creating innovative and effective products that cater to the needs of consumers across the globe.
How the Company Makes MoneyEdgewell Personal Care generates revenue primarily through the sale of its personal care products across various categories including grooming, sun care, skin care, and feminine care. The company's key revenue streams include sales from its grooming products like razors and blades under the Schick and Wilkinson Sword brands, sun care products under Banana Boat and Hawaiian Tropic, and skin care and hygiene products such as Wet Ones. Edgewell sells its products through a combination of retail partners, including mass merchandisers, drugstores, supermarkets, and e-commerce platforms. Strategic partnerships and licensing agreements, along with a focus on innovation and brand development, further contribute to Edgewell's earnings.

Edgewell Personal Care Earnings Call Summary

Earnings Call Date:May 07, 2025
(Q2-2025)
|
% Change Since: -22.41%|
Next Earnings Date:Aug 12, 2025
Earnings Call Sentiment Neutral
The earnings call highlighted significant international growth and strong brand performance in specific areas like the Billie brand. However, this was offset by challenges in North America, including declines in Sun Care and Fem Care sales, and the impact of tariffs on costs. The outlook for the second half of the fiscal year is cautious due to expected lower consumption trends.
Q2-2025 Updates
Positive Updates
Record International Growth
International markets saw 3% organic growth, marking the 12th growth quarter in the last 13. This growth was driven by both price and volume gains.
Productivity Savings
Edgewell realized approximately 380 basis points of productivity savings, which contributed to a 110 basis points constant currency gross margin accretion.
Strong Brand Performance
The Billie brand saw significant market share gains, reaching a 15% share at Walmart and 14% at Target in women's systems.
Successful International Innovations
Notable product launches in international markets included the expansion of the Billie brand to Australia and new product innovations in Japan.
Negative Updates
Decline in North America Sales
Organic sales in North America declined about 4%, driven by declines in Sun, Shave Preps, and Fem Care.
Tariff-Related Cost Impact
The in-year cost impact of tariffs is estimated to be $3 million to $4 million, with an annualized exposure of 3% to 4% of COGS.
Lower U.S. Sun Care Sales
Sun Care sales in the U.S. declined due to poor weather and order phasing related to the Easter holiday.
Fem Care Portfolio Struggles
Fem Care organic sales declined 9%, with the category showing slow recovery and consumption declines in tampons and pads.
Company Guidance
During Edgewell's Second Quarter Fiscal Year 2025 Earnings Call, the company provided guidance reflecting a cautious outlook due to a challenging macroeconomic environment. They revised their full-year organic net sales growth expectation to a range of flat to 1%, with a forecast of 2% growth in the second half. The company anticipates full-year adjusted earnings per share to be between $2.85 and $3.05, impacted by approximately $0.35 per share in currency headwinds. Adjusted EBITDA is expected to be in the range of $329 million to $341 million, also inclusive of currency impacts. Tariffs are anticipated to have a $3 million to $4 million impact on COGS for fiscal 2025, with an annualized exposure of 3% to 4% of COGS. Despite these challenges, Edgewell is incrementally investing in North America, particularly in Sun Care and Women's Shave, to strengthen market position and anticipates sequential improvement in the region's performance.

Edgewell Personal Care Financial Statement Overview

Summary
Edgewell Personal Care demonstrates stable financial health with consistent profitability and a solid balance sheet, though revenue growth has stagnated. The company maintains a balanced capital structure and strong cash flow management, suggesting resilience in its operations. While there are concerns regarding debt levels and EBIT margins, the overall financial position remains stable, supporting continued operations and potential future growth opportunities.
Income Statement
76
Positive
Edgewell Personal Care shows stable revenue with a slight decline in the TTM period compared to the prior year. Gross Profit Margin for TTM stands at approximately 42.6%, and Net Profit Margin is 3.8%, indicating moderate profitability. Despite a decrease in EBIT and EBITDA margins to 8.4% and 12.5% respectively, the company maintains reasonable profitability levels, but the revenue growth remains stagnant, which could be a concern for future growth.
Balance Sheet
69
Positive
The balance sheet indicates a moderate Debt-to-Equity ratio of 0.98, reflecting balanced leverage. ROE is at 5.6%, showing a decent return on shareholder equity but with room for improvement. The Equity Ratio is 40.1%, suggesting a stable capital structure with sufficient equity backing the assets. However, the increase in debt over recent periods could pose a potential risk if not managed carefully.
Cash Flow
82
Very Positive
Free Cash Flow has grown to $32 million in the TTM period, although overall Operating Cash Flow decreased compared to the previous year. The Operating Cash Flow to Net Income Ratio is 1.23, indicating strong cash generation relative to net income. Despite the decline in Operating Cash Flow, the company effectively manages its capital expenditures to maintain positive Free Cash Flow, which is a positive indicator for liquidity.
Breakdown
TTMSep 2024Sep 2023Sep 2022Sep 2021Sep 2020
Income StatementTotal Revenue
2.22B2.25B2.25B2.17B2.09B1.95B
Gross Profit
947.70M955.70M938.40M879.40M950.10M880.90M
EBIT
186.20M199.30M224.60M181.20M238.80M195.20M
EBITDA
279.10M285.50M317.60M285.40M301.00M237.30M
Net Income Common Stockholders
84.70M98.60M114.70M99.50M117.80M67.60M
Balance SheetCash, Cash Equivalents and Short-Term Investments
170.10M209.10M216.40M188.70M479.20M364.70M
Total Assets
3.77B3.73B3.74B3.71B3.67B3.54B
Total Debt
1.48B1.30B1.45B1.41B1.26B1.26B
Net Debt
1.31B1.09B1.23B1.22B781.50M894.30M
Total Liabilities
2.26B2.15B2.20B2.25B2.09B2.11B
Stockholders Equity
1.51B1.58B1.54B1.46B1.58B1.43B
Cash FlowFree Cash Flow
32.00M174.50M166.60M45.60M172.20M184.90M
Operating Cash Flow
104.40M231.00M216.10M102.00M229.00M232.60M
Investing Cash Flow
-75.70M-62.40M-50.50M-355.40M-48.70M-196.40M
Financing Cash Flow
131.90M-179.40M-146.50M-17.60M-65.40M-18.70M

Edgewell Personal Care Technical Analysis

Technical Analysis Sentiment
Negative
Last Price23.16
Price Trends
50DMA
28.29
Negative
100DMA
29.59
Negative
200DMA
32.32
Negative
Market Momentum
MACD
-1.02
Positive
RSI
25.46
Positive
STOCH
3.33
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For EPC, the sentiment is Negative. The current price of 23.16 is below the 20-day moving average (MA) of 26.78, below the 50-day MA of 28.29, and below the 200-day MA of 32.32, indicating a bearish trend. The MACD of -1.02 indicates Positive momentum. The RSI at 25.46 is Positive, neither overbought nor oversold. The STOCH value of 3.33 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for EPC.

Edgewell Personal Care Risk Analysis

Edgewell Personal Care disclosed 23 risk factors in its most recent earnings report. Edgewell Personal Care reported the most risks in the "Production" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Edgewell Personal Care Peers Comparison

Overall Rating
UnderperformOutperform
Sector (65)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
82
Outperform
$4.54B26.4422.16%2.35%10.32%18.55%
EPEPC
65
Neutral
$1.09B13.525.53%2.59%-2.11%-28.79%
65
Neutral
$8.81B14.924.67%6.17%3.60%-2.89%
64
Neutral
$620.83M5.017.45%-4.93%-23.61%
NUNUS
62
Neutral
$373.56M-4.93%3.17%-11.85%-1080.00%
SPSPB
58
Neutral
$1.29B24.742.79%3.63%1.46%-95.70%
NWNWL
52
Neutral
$2.27B-8.46%5.16%-6.09%17.71%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
EPC
Edgewell Personal Care
23.16
-15.41
-39.95%
HELE
Helen Of Troy
27.06
-72.59
-72.84%
IPAR
Inter Parfums
136.06
26.77
24.49%
NWL
Newell Brands
5.24
-1.27
-19.51%
NUS
Nu Skin
7.56
-4.32
-36.36%
SPB
Spectrum Brands Holdings
51.73
-35.83
-40.92%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.